Age-related Macular Degeneration (AMD) Drugs Market worth $17.37 billion by 2029
The report "Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029 ", is projected to reach USD 17.37 billion by 2029 from USD 10.46...
0 Comments 0 Shares